Patent Application: Compounds for Inhibiting IL-17
Summary
The USPTO has published a patent application (US20260083708A1) detailing compounds for inhibiting IL-17 activity. The application, filed on December 1, 2025, describes compounds and methods for treating inflammatory and autoimmune disorders.
What changed
This document is a published patent application from the USPTO detailing novel compounds designed to inhibit or regulate the activity of Interleukin-17 (IL-17). The application, identified as US20260083708A1, includes specific chemical structures (Formula I) and outlines methods for treating inflammatory and autoimmune diseases. The filing date was December 1, 2025.
As this is a patent application, it represents a disclosure of potential new intellectual property rather than a regulatory mandate. Companies in the pharmaceutical and biotechnology sectors involved in the research and development of treatments for inflammatory and autoimmune disorders may find this application relevant for competitive intelligence and potential licensing opportunities. There are no immediate compliance obligations or deadlines associated with this publication.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IL-17 MODULATORS AND USES THEREOF
Application US20260083708A1 Kind: A1 Mar 26, 2026
Inventors
Yucheng PANG, Feiyang XU, Xiangyang CHEN
Abstract
The present invention relates to compounds suitable for inhibiting or regulating the activity of IL-17. The present invention is directed to compounds shown in Formula (I) and their pharmaceutically acceptable salts thereof. The present invention further relates to methods for treating and/or preventing various human diseases, including inflammatory and autoimmune disorders. The present invention also provides methods for preparing the compounds of the present invention.
CPC Classifications
A61K 31/4196 A61P 19/02 C07D 401/10
Filing Date
2025-12-01
Application No.
19405049
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.